results of a longitudinal study. (Kongress ISPOG 2010) Noeres D, von Garmissen A, Neises M. Geyer S. Breast Cancer Knowledge in Self-Help Groups. (Kongress ESHMS 2010, Ghent) Noeres D, Prochnow A, Geyer S [...] Jaunzeme J, Geyer S (2013). Return to work after treatment for primary breast cancer over a six-year period: Results from a prospective study comparing patients with the general population. Supportive Care in [...] e zu Life-Events bei Patientinnen mit Brustkrebs. Das Gesundheitswesen, 71-A50 dx.doi.org/10.1055/s-0029-1239100 Garmissen A v (2009). Sinnstiftende Faktoren, religiöse Werthaltungen und Krankheitsbwältigung

Publikationen und Vorträge Noeres D, Sperlich S, Röbbel L, Safieddine B, Deuker J U, Hillemanns P, Ismaéel F, Moser A, Noeding K-H, Noesselt T, Pape J, Park-Simon T-W, Peschel S, Seifert W, Siggelkow W, Thoma

infections after kidney transplantation. J Nucl Med. 2017;58:1831-1837. Derlin T , Alchalby H, Bannas P, Laqmani A, Ayuk F, Triviai I, Kreipe HH, Bengel FM, Kröger N. Serial 18F-FDG PET for Monitoring Treatment [...] Christiansen H, Thackeray JT, Ross TL, Bengel FM. PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence [...] Initial Experience with Volumetric 68Ga-PSMA I&T PET/CT for Assessment of Whole-body Tumor Burden as a Quantitative Imaging Biomarker in Patients with Prostate Cancer . J Nucl Med. 2017;58:1962-1968. Schmuck

S, Kopp J, Rovai A, Varnholt D, Wachs AS, Goyenvalle A, Aarstma-Rus A, Ott M, Tiede A, Langemeier J, Bohne J. Pathological mechanism and antisense oligonucleotide-mediated rescue of a non-coding variant [...] 8690. 3. Krooss SA, Dai Z, Schmidt F, Rovai A, Fakhiri J, Dhingra A, Yuan Q, Yang T, Balakrishnan A, Steinbrück L, Srivaratharajan S, Manns MP, Schambach A, Grimm D, Bohne J , Sharma AD, Büning H, Ott [...] interested in non-coding mutations causing various human diseases. Both areas follow our central idea: A deeper knowledge of both viral gene expression and the pathomechanisms of non-coding mutations will

control maternofetal priming of allergy and tolerance in a murine model of allergic airway inflammation. Happle C, Jirmo A, Meyer-Bahlburg A, Habener A, Hoymann H.G, Hennig C, Skuljec J, Hansen G., J Allergy [...] ameliorates Pulmonary Alveolar Proteinosis. Happle C, Lachmann N, Ackermann M, Mirenska A, Göhring G, Thomay K, Mucci A, Glomb T, Suzuki T, Chalk C, Glage S, Dittrich-Breiholz O, Trapnell B, Moritz T, Hansen [...] proteinosis. Happle C, Lachmann N, Skuljec J, Wetzke M, Ackermann,M, Brennig S, Mucci A, Jirmo AC, Groos S, Mirenska A, Hennig C, Rodt T, Bankstahl JP, Schwerk N, Moritz T, Hansen G., Science Transl Med

supervisor: Dr. A. Braun, Fraunhofer-Institute, Nicolai-Fuchs-Str. 1, 30625 Hannover, project: Mechanisms of neurogenic inflammation in asthma bronchiale: role of the neurotrophin receptors TrkA, TrkB, TrkC [...] supervisor: Prof. Dr. Gessner, Clinical Immunology, project: Analysis of the coupling mechanism between C5a anaphylatoxin and FcgRs in Ab-dependent models of nephritis, alveolitis and autoimmune hemolytic anemia [...] Prof. Dr. Just, Toxicology, project: Pro-inflammatory effects of the Clostridium difficile toxins A and B Final exam November 2006 Anika Hoffmann, nee Meyerholz (Dr. med.) GERMANY supervisor: Prof. Dr

medical ethics: A framework for changing practice according to normative ethical requirements . Bioethics 38:241-251 Kremling A, Schildmann J, Mertz M (2024) From book to bedside? A critical perspective [...] im Gesundheitswesen (IQWiG), Köln Köpke S, Boes J, Möhler R, Schamong A, Brockmeier K, Icks A, Marckmann G, Mertz M, Otto I, Bäumer A (2022) HT20-02: Herzerkrankung bei Kindern: Können Kinder durch eine [...] method in basic and preclinical biomedical research? A spectrum of ethically relevant reasons and their evaluation . Animals 14(4):651 2023 Kahrass H, Borry P, Gastmans C, Ives J, van der Graaf R, Strech D,

mit akutem Nierenversagen). Ausgewählte Publikationen Eden G, Schmidt JJ, Büttner S, Kümpers P, Hafer C, Rovas A, Koch BF, Schmidt BMW, Kielstein JT. Safety and efficacy of the Seraph® 100 Microbind® Affinity [...] Gottlieb J, Eder M, Welte T, Hoeper MM, Scherag A, David S. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care

DG/PARO - „Analyse der Entwicklung von γδ T-Zellen in der murinen Gingiva und ihrer Funktion bei der P. gingivalis-induzierten Parodontitis“ Kooperation mit AG Prof. Stiesch, MHH 10/2013–10/2017 DFG Sachbeihilfe [...] Verhinderung der Graft-versus-Host Erkrankung 07/2009-06/2013 DFG Sonderforschungsbereich 621, Teilprojekt A14 - Untersuchung der Funktion, Spezifizität und Migration von γδ T-Zellen und ihrer Bedeutung für p

07.2022 ECAT 2022-P2-PFA-25.07.2022 ECAT 2022-M2-Main-ADAMTS13-02.08.2022 ECAT 2022-M3-Main-ADAMTS13-05.11.2022 ECAT 2022-L3-LUPUS-10.11.2022 ECAT 2022-P4-PFA-12.01.2023 ECAT 2022-L4(A)-LUPUS-25.01.2023 [...] bis 09/25) Immunsuppressiva (gültig bis 08/25) Zertifikate 2025 A (PDF-Format) Hormone 1 (gültig bis 04/25) Hormone 2 (gültig bis 04/25) HbA1c (gültig bis 04/25) Tumormarker (gültig bis 04/25) Klinische [...] ion 11.04.2025 Instand Molekulargenetik 06- Prothrombin G20210A 11.04.2025 ECAT 2025-H1-Heamophilia-F.IX Inhibitor-22.04.2025 ECAT 2025-P1-PFA-29.04.2025 ECAT 2025-M1-Main-ADMTS13-10.05.2025 ECAT 2025